Evaluate the Effects of Tolcapone on Cognitive and Behavioral Dysfunction in Patients With BI and NCD

NCT02652598 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Brain Injuries, Traumatic
Neurocognitive Disorders
Brain Injuries

Interventions

DRUG: Tolcapone

Sponsor

Sheppard Pratt Health System

Collaborators

[object Object]